NOTE 7 - COMMON STOCK OPTIONS (Detail) (USD $)	12 Months Ended																						12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2009 Director [Member] Stock options issued August 26, 2009 [Member]	Dec. 31, 2012 Director [Member] 2012 Equity Incentive Award Plan [Member]	Dec. 31, 2009 Options Granted to Consultants [Member] Stock options issued August 26, 2009 [Member]	Dec. 31, 2011 Options granted March 2011 [Member]	Dec. 31, 2012 Options granted to officers, consultants and employees, February 2012 [Member] 2012 Equity Incentive Award Plan [Member]	Dec. 31, 2012 Options granted February 2012 [Member] 2012 Equity Incentive Award Plan [Member]	Dec. 31, 2012 Options issued for distribution related services, May 2012 [Member] 2012 Equity Incentive Award Plan [Member]	Dec. 31, 2012 Options granted for medical consulting support services, May 2012 [Member] 2012 Equity Incentive Award Plan [Member]	Dec. 31, 2012 Restricted shares issued for cash, August 2012 [Member] 2012 Equity Incentive Award Plan [Member]	Dec. 31, 2012 Minimum [Member]	Dec. 31, 2012 Maximum [Member]	Dec. 31, 2012 Stock options issued August 26, 2009 [Member]	Dec. 31, 2012 Stock options issued July 2010 [Member]	Dec. 31, 2011 Stock options issued July 2010 [Member]	Dec. 31, 2010 Stock options issued July 2010 [Member]	Dec. 31, 2012 Options granted September 2010 [Member]	Dec. 31, 2010 Options granted September 2010 [Member]	Dec. 31, 2011 Options granted March 2011 [Member]	Dec. 31, 2011 Options granted for web and press support services, March 2011 [Member]	Dec. 31, 2012 2012 Equity Incentive Award Plan [Member]	Dec. 31, 2012 2012 Equity Incentive Award Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			1,000,000	1,000,000	1,500,000		1,050,000		1,000,000	1,000,000	2,500,000						3,500,000		250,000	150,000	100,000
Investment Options, Exercise Price (in Dollars per share)			$ 0.10	$ 0.23	$ 0.10		$ 0.23		$ 0.17	$ 0.17	$ 0.05						$ 0.20		$ 0.275	$ 0.14
Stock option, term			5 years		5 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights					i) options for purchase of 500,000 shares vested immediately on the date of grant, ii) options for 500,000 shares will vest on the date certified by the Company as the date the Company's hospital disinfection program completes its beta-testing (completed in 2012), and iii) the remaining options will vest on the date certified by the Company as the date that the Company's process has been commercialized and a minimum of 50 units or devices have been sold to third parties by the Company.
Share Based Compensation Arrangement by Share Based Payment Award, Options, Vested In Period									100,000	670,000				500,000	3,250,000
Share-based Compensation (in Dollars)	$ 1,946,725	$ 33,403				$ 20,042		$ 1,057,600	$ 15,399	$ 100,138	$ 0			$ 48,699	$ 659,822			$ 65,067			$ 13,361
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number	237,000													500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period																250,000
Share Based Compensation Arrangement by Share Based Payment Award, Options, Term									5	5							5		5	5	5
Stock option, exercise price (in Dollars per share)																					$ 0.14
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized																						10,000,000
Number of directors issued shares																							4
Share Based Compensation Arrangement by Share Based Payment Award, Options Fair Value, Grants in Period (in Dollars)									$ 153,997	$ 149,460
Number of Investors Granted Options											3
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term												20 years	52 years